Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,205 public trials 1,002 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

SW-682 in Advanced Solid Tumors

NCT06251310

Conditions
Adenoma, Advanced Solid Tumor, Lung Diseases, +12 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UC San Diego Moores Cancer Center Sacramento, California, United States
  • UCLA Hematology-Oncology - Santa Monica Santa Monica, California, United States
View Trial Details
Recruiting

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

NCT07166601

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Princess Margaret Cancer Centre Toronto, Canada
View Trial Details
Recruiting

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

NCT06892548

Conditions
Advanced Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • UCLA - David Geffen School of Medicine Santa Monica, California, United States
View all 88 locations
View Trial Details
Recruiting

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

NCT07028489

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • Torrance Memorial Physician Network-Cancer Care Torrance, California, United States
  • John Muir Health Walnut Creek, California, United States
  • Bayhealth Cancer Center- Kent Dover, Delaware, United States
View Trial Details
Recruiting

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

NCT07005128

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small-cell Lung Cancer, +9 more
Locations
  • Cancer and Blood Specialists of Arizona Casa Grande, Arizona, United States
  • City of Hope Cancer Center Phoenix Goodyear, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Saint Bernards Medical Center Jonesboro, Arkansas, United States
View all 164 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

NCT07306624

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Catholic University of Korea St. Vincent's Hospital Gyeonggi-do, South Korea
  • Kangbuk Samsung Hospital Seoul, South Korea
  • Korea University Anam Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Recruiting

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NCT07397338

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +22 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Dallas Irving, Texas, United States
View Trial Details

Related conditions